Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins.
about
ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein CDisease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradationHuman oligodendrocytes express Cx31.3: function and interactions with Cx32 mutantsLoss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like diseaseThe delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiologySystemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.Divergent effects of two sequence variants of GJB3 (G12D and R32W) on the function of connexin 31 in vitroDefining a minimal motif required to prevent connexin oligomerization in the endoplasmic reticulumInefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surfaceAutophagy modulates dynamics of connexins at the plasma membrane in a ubiquitin-dependent mannerIdentification of a dimerization domain in the TMEM16A calcium-activated chloride channel (CaCC)Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defectsRab2A is a pivotal switch protein that promotes either secretion or ER-associated degradation of (pro)insulin in insulin-secreting cells.Phenotypes and cellular effects of GJB1 mutations causing CMT1X in a cohort of 226 Chinese CMT families.Identification of rab20 as a potential regulator of connexin 43 trafficking.Modularity of the Hrd1 ERAD complex underlies its diverse client range.CamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene.Evasion of endoplasmic reticulum surveillance makes Wsc1p an obligate substrate of Golgi quality controlLow pH enhances connexin32 degradation in the pancreatic acinar cell.Sequential actions of the AAA-ATPase valosin-containing protein (VCP)/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.Regulation of lens gap junctions by Transforming Growth Factor beta.Mechanisms of gap junction traffic in health and diseaseVoltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth diseaseDegradation of a connexin40 mutant linked to atrial fibrillation is accelerated.Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductaseMembrane traffic in myelinating oligodendrocytes.Syndromic and non-syndromic disease-linked Cx43 mutations.Autophagy: a pathway that contributes to connexin degradation.Human connexin disorders of the skin.Sharing signals: connecting lung epithelial cells with gap junction channels.The connexin46 mutant, Cx46T19M, causes loss of gap junction function and alters hemi-channel gatingCardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir)Connexin gene pathology.Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsEvolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD).Changes in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin.Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsMissense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.
P2860
Q24318838-82D5F223-1D9E-453B-BD69-15356183DEC4Q24544268-0264FE59-E3C2-4FEF-99EF-796A8E39DD9DQ24653719-93B97B5A-BA89-4F56-8E45-82FB85EC5629Q24655300-8FEF8E67-ECBF-4077-9307-40B13F04A6AAQ24682835-9C298CD3-F323-414F-8995-0AD041067BA2Q27015793-8BF0E2FC-E56C-42F2-AF11-B220045AECC8Q27316720-AC83B39E-8399-422E-B8A2-861BDB3EAE4FQ28191724-44B80B50-A231-46A6-B623-0892EAC2965EQ28564736-AF1871F6-D380-42D1-8AAE-1CBC500F2F25Q28577566-7618A1E5-9892-4ABF-A7C5-2E9B8CD9C41DQ28590933-1322E019-045B-4F2D-A214-F5E630785673Q28592114-1E53A6FB-74C3-4A30-83EE-8A4A5A2DA71BQ30485962-90418EDB-7775-4530-A984-4BBA1C26CDF4Q30844266-47F8A79C-E8BE-4E20-B86B-10FA916881A7Q32186771-EA361808-86DF-4B50-B208-80AEEB1B904AQ33354230-1EB4B264-6752-44C2-A628-94FD85ED972EQ33717057-A5C5DC3C-B6F2-444C-8D74-EC24191C335AQ33750892-86BA49A2-81DF-41D5-8C87-A58A598A5CC2Q33761462-D0B67652-9E0E-4509-BC14-2587FD7E273EQ33840000-FBE0D82C-4B4D-4130-B666-209E93D96BDAQ33846508-3D034500-CFF5-4BB7-9552-E304CE7584BFQ33848751-5AF5B574-7111-41AE-9BFB-C306B55E094DQ34017761-7E3BC342-0BB0-4645-804A-207FA246BE12Q34021416-6EF804B5-0DA9-4648-BE75-AC094154A8E0Q34055972-435D5F6E-9410-4859-9E2F-E6263E2E7BE5Q34119006-5361EE5F-3ABB-4A5D-863A-AEA68D729E87Q34199609-444D51FE-6222-4DFB-9EAF-1544DAC2F166Q34398416-66B84186-7354-453A-9819-72E3A8492888Q34625117-B2A56959-6211-4DCB-B8E1-6FB126587D14Q34685630-044A3632-9635-4595-993C-062C7024E3DBQ34958828-92EB4175-77F4-4C67-8A5A-BBD2DFE691E9Q34990414-DF509444-E851-4E12-BC1B-B971270225F7Q35009815-A6DAE44E-B0FD-4763-BF97-B6A573C7BAACQ35161187-0D03EF99-2E17-4BA4-958E-BE295120BCD6Q35191051-B74EFAEB-6A4F-4E65-A39C-F5A3ECA28E99Q35206022-C4256295-3E0B-408B-A412-A6A02E76F268Q35227496-2916DC5B-7CC9-44EB-9F3F-2823EA705EBDQ35238349-3A06CF7A-DFAD-4D48-8681-82D0D1C3CC92Q35764888-2989848A-966A-4A2D-8822-B3D29AB1B3C0Q35895439-49A8AFFE-8BAB-4C45-82EB-922C5BA92AEA
P2860
Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intracellular transport, assem ...... mutant gap junction proteins.
@ast
Intracellular transport, assem ...... mutant gap junction proteins.
@en
Intracellular transport, assem ...... mutant gap junction proteins.
@nl
type
label
Intracellular transport, assem ...... mutant gap junction proteins.
@ast
Intracellular transport, assem ...... mutant gap junction proteins.
@en
Intracellular transport, assem ...... mutant gap junction proteins.
@nl
prefLabel
Intracellular transport, assem ...... mutant gap junction proteins.
@ast
Intracellular transport, assem ...... mutant gap junction proteins.
@en
Intracellular transport, assem ...... mutant gap junction proteins.
@nl
P2093
P2860
P356
P1476
Intracellular transport, assem ...... mutant gap junction proteins.
@en
P2093
J K VanSlyke
S M Deschenes
P2860
P304
P356
10.1091/MBC.11.6.1933
P577
2000-06-01T00:00:00Z